Once more, the lncRNA MEG3 influences various mechanisms, notably triggering the mitochondrial apoptosis pathway via p53 activation and decreasing Bcl-xl levels, thereby modulating the sensitivity to cisplatin in NSCLC [145]. Here, TP53 is linked to non-small cell lung carcinoma.